BR112012012903A2 - compostos de espiropiperidina - Google Patents

compostos de espiropiperidina

Info

Publication number
BR112012012903A2
BR112012012903A2 BR112012012903A BR112012012903A BR112012012903A2 BR 112012012903 A2 BR112012012903 A2 BR 112012012903A2 BR 112012012903 A BR112012012903 A BR 112012012903A BR 112012012903 A BR112012012903 A BR 112012012903A BR 112012012903 A2 BR112012012903 A2 BR 112012012903A2
Authority
BR
Brazil
Prior art keywords
spiropiperidine compounds
spiropiperidine
compounds
compound
formula
Prior art date
Application number
BR112012012903A
Other languages
English (en)
Portuguese (pt)
Inventor
Hamdouchi Chafiq
Pankaj Lineswala Jayana
Maiti Pranab
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43384775&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112012012903(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR112012012903A2 publication Critical patent/BR112012012903A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4747—Quinolines; Isoquinolines spiro-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR112012012903A 2009-11-30 2010-11-19 compostos de espiropiperidina BR112012012903A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26518109P 2009-11-30 2009-11-30
PCT/US2010/057359 WO2011066183A1 (en) 2009-11-30 2010-11-19 Novel spiropiperidine compounds

Publications (1)

Publication Number Publication Date
BR112012012903A2 true BR112012012903A2 (pt) 2017-03-01

Family

ID=43384775

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012012903A BR112012012903A2 (pt) 2009-11-30 2010-11-19 compostos de espiropiperidina

Country Status (26)

Country Link
US (1) US8822486B2 (cg-RX-API-DMAC7.html)
EP (1) EP2507228B1 (cg-RX-API-DMAC7.html)
JP (1) JP5709889B2 (cg-RX-API-DMAC7.html)
KR (1) KR101410103B1 (cg-RX-API-DMAC7.html)
CN (1) CN102648195B (cg-RX-API-DMAC7.html)
AR (1) AR078948A1 (cg-RX-API-DMAC7.html)
AU (1) AU2010324987B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012012903A2 (cg-RX-API-DMAC7.html)
CA (1) CA2781292C (cg-RX-API-DMAC7.html)
CL (1) CL2012001321A1 (cg-RX-API-DMAC7.html)
CR (1) CR20120296A (cg-RX-API-DMAC7.html)
DO (1) DOP2012000139A (cg-RX-API-DMAC7.html)
EA (1) EA020507B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP12011930A (cg-RX-API-DMAC7.html)
ES (1) ES2526568T3 (cg-RX-API-DMAC7.html)
GT (1) GT201200164A (cg-RX-API-DMAC7.html)
IL (1) IL219594A0 (cg-RX-API-DMAC7.html)
MA (1) MA33840B1 (cg-RX-API-DMAC7.html)
MX (1) MX2012006233A (cg-RX-API-DMAC7.html)
NZ (1) NZ600203A (cg-RX-API-DMAC7.html)
PE (1) PE20121474A1 (cg-RX-API-DMAC7.html)
PH (1) PH12012501052A1 (cg-RX-API-DMAC7.html)
TN (1) TN2012000248A1 (cg-RX-API-DMAC7.html)
TW (1) TW201141866A (cg-RX-API-DMAC7.html)
WO (1) WO2011066183A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201203055B (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR078522A1 (es) 2009-10-15 2011-11-16 Lilly Co Eli Compuesto de espiropiperidina, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para tratar diabetes y compuesto intermediario para su sintesis
PH12012501456A1 (en) 2009-12-25 2012-10-29 Mochida Pharm Co Ltd Novel 3-hydroxy -5- arylisothiazole derivative
AU2011313191A1 (en) 2010-10-08 2013-05-02 Mochida Pharmaceutical Co., Ltd. Cyclic amide derivative
AR085990A1 (es) 2011-04-27 2013-11-13 Mochida Pharm Co Ltd Derivados de 1-oxido de 3-hidroxiisotiazol utiles en el tratamiento de la diabetes y composiciones farmaceuticas que los contienen
JPWO2012147516A1 (ja) 2011-04-28 2014-07-28 持田製薬株式会社 環状アミド誘導体
AR087451A1 (es) 2011-08-17 2014-03-26 Lilly Co Eli Derivado de 1,2,3,4-tetrahidroquinolina util para tratamiento de diabetes
WO2014159054A1 (en) * 2013-03-14 2014-10-02 Janssen Pharmaceutica Nv Gpr120 agonists for the treatment of type ii diabetes
CN105722841A (zh) 2013-11-14 2016-06-29 卡迪拉保健有限公司 新型杂环化合物
WO2015084692A1 (en) 2013-12-04 2015-06-11 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
US10059667B2 (en) 2014-02-06 2018-08-28 Merck Sharp & Dohme Corp. Antidiabetic compounds
WO2018166855A1 (en) 2017-03-16 2018-09-20 Basf Se Heterobicyclic substituted dihydroisoxazoles
BR102018007822A2 (pt) 2017-04-20 2018-11-06 Gilead Sciences, Inc. composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição
WO2019160882A1 (en) 2018-02-13 2019-08-22 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
KR102591947B1 (ko) 2018-04-19 2023-10-25 길리애드 사이언시즈, 인코포레이티드 Pd-1/pd-l1 억제제
PE20210642A1 (es) 2018-07-13 2021-03-23 Gilead Sciences Inc Inhibidores de pd-1/pd-l1
US11236085B2 (en) 2018-10-24 2022-02-01 Gilead Sciences, Inc. PD-1/PD-L1 inhibitors
CN110590767B (zh) * 2019-08-29 2021-10-08 南方科技大学 一种合成amg837的方法
JP2022552655A (ja) 2019-10-07 2022-12-19 キャリーオペ,インク. Gpr119アゴニスト
MX2022010548A (es) 2020-02-28 2022-09-23 Kallyope Inc Agonistas de gpr40.
MX2022014505A (es) 2020-05-19 2022-12-13 Kallyope Inc Activadores de la ampk.
CA3183575A1 (en) 2020-06-26 2021-12-30 Iyassu Sebhat Ampk activators

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0202133D0 (sv) * 2002-07-08 2002-07-08 Astrazeneca Ab Novel compounds
CA2520114A1 (en) 2003-04-04 2004-10-21 Merck & Co., Inc. Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
US7504506B2 (en) 2003-11-04 2009-03-17 Elixir Pharmaceuticals, Inc. Therapeutic compounds and uses thereof
EP1737809B1 (en) 2004-02-27 2013-09-18 Amgen, Inc Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
JP4859665B2 (ja) * 2004-03-30 2012-01-25 武田薬品工業株式会社 アルコキシフェニルプロパン酸誘導体
CA2579204A1 (en) * 2004-09-07 2006-03-16 Banyu Pharmaceutical Co., Ltd. Carbamoyl-substituted spiro derivative
MX2009000475A (es) * 2006-07-19 2009-07-10 Astrazeneca Ab Nuevos compuestos de espiropiperidina triciclicos, su sintesis y sus usos como moduladores de la actividad de los receptores de quimioquinas.
EP2072519A4 (en) * 2006-09-28 2009-10-21 Banyu Pharma Co Ltd DIARYLKETIMINDERIVAT
PT2125827E (pt) * 2006-12-29 2010-11-22 Hoffmann La Roche Derivados azaespiro
ES2446419T3 (es) * 2007-04-16 2014-03-07 Amgen, Inc Moduladores de GPR40 de ácidos bifenilfenoxi, tiofenil y aminofenilpropanoico sustituidos
TWI421070B (zh) * 2007-10-26 2014-01-01 Japan Tobacco Inc 螺化合物及其醫藥用途
AR078522A1 (es) 2009-10-15 2011-11-16 Lilly Co Eli Compuesto de espiropiperidina, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para tratar diabetes y compuesto intermediario para su sintesis
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament

Also Published As

Publication number Publication date
IL219594A0 (en) 2012-06-28
US8822486B2 (en) 2014-09-02
CA2781292A1 (en) 2011-06-03
CR20120296A (es) 2012-07-16
MX2012006233A (es) 2012-07-03
EP2507228B1 (en) 2014-11-05
PH12012501052A1 (en) 2013-02-04
JP5709889B2 (ja) 2015-04-30
CN102648195A (zh) 2012-08-22
GT201200164A (es) 2014-02-27
EP2507228A1 (en) 2012-10-10
US20120220616A1 (en) 2012-08-30
ZA201203055B (en) 2013-09-25
AU2010324987B2 (en) 2014-01-30
KR101410103B1 (ko) 2014-06-25
CN102648195B (zh) 2015-01-07
CA2781292C (en) 2014-04-22
EA201290416A1 (ru) 2012-11-30
DOP2012000139A (es) 2012-08-15
TW201141866A (en) 2011-12-01
AR078948A1 (es) 2011-12-14
WO2011066183A1 (en) 2011-06-03
JP2013512277A (ja) 2013-04-11
MA33840B1 (fr) 2012-12-03
ECSP12011930A (es) 2012-07-31
PE20121474A1 (es) 2012-11-05
EA020507B1 (ru) 2014-11-28
KR20120088770A (ko) 2012-08-08
NZ600203A (en) 2013-09-27
TN2012000248A1 (en) 2013-12-12
CL2012001321A1 (es) 2013-11-15
ES2526568T3 (es) 2015-01-13
AU2010324987A1 (en) 2012-07-26

Similar Documents

Publication Publication Date Title
BR112012008889A2 (pt) compostos de espiropiperidina e uso farmacêutico dos mesmos para tratar diabetes
EP2415749A4 (en) NOVEL SALVIANOLIC ACID COMPOUND L, PROCESS FOR THE PREPARATION AND USE
TN2012000248A1 (en) Novel spiropiperidine compounds
EA201491060A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
BR112012019762A2 (pt) composto, composição, e, método para tratar uma doença.
BR112014027359A2 (pt) moduladores da série de reação complementar e usos dos mesmos
EA201692506A2 (ru) Ингибиторы репликации вирусов гриппа
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
MX2019003738A (es) Compuestos antivirales.
MX2013007336A (es) Compuestos de bi-heteroarilo como inhibidores de vps34.
MX2011011335A (es) Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamifero de rapamicina.
EA201690521A1 (ru) Способ получения замещенных 5-фтор-1h-пиразолопиридинов
EA201270216A1 (ru) Фармацевтический состав
BR112014003079A2 (pt) derivado de 1,2,3,4-tetra-hidroquinolina útil para o tratamento de diabetes
EA201391525A1 (ru) Гликозидные производные и их применение для лечения диабета
CR20140036A (es) Compuesto inhibidor de la señalización de la trayectoria notch
UY31803A (es) Compuesto cristalino
WO2010150211A3 (en) Use of derivatives of indoles for the treatment of cancer
BR112012013918A2 (pt) inibidores de diacil glicerol acil transferase
MX2013006670A (es) Derivado de 2-carboxamida-4-piperazinil-benzofurano.
IN2014DN03010A (cg-RX-API-DMAC7.html)
BR112014000485A2 (pt) derivados de azetidina para o tratamento de transtornos relacionados à melanina
MX2013011561A (es) Compuestos de benzodioxepina y benzodioxina que interactuan con la proteina reguladora de glucocinasa para el tratamiento de diabetes.
BR112013027982A2 (pt) derivados de isoindolinona
WO2014147578A3 (en) Antibacterial compounds against drug resistant bacteria

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]